{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:11:16Z","timestamp":1790640676718,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Transcatheter aortic valve implantation (TAVI) has transformed the management of severe aortic stenosis (AS), evolving from a therapy reserved for inoperable patients to a viable treatment across the spectrum of surgical risk. This success has stimulated innovation in transcatheter therapies for other valvular heart diseases, including aortic regurgitation (AR). In contrast to AS, AR is characterised by heterogeneous aetiologies, absence of annular calcification, larger and more elliptical annular dimensions, and concomitant aortopathy. These challenges have limited the efficacy and safety of conventional transcatheter aortic valves (TAVs), use of which in pure native AR is associated with high rates of valve embolisation, significant residual regurgitation, permanent pacemaker implantation, and mortality. The development of dedicated TAVs designed specifically for the treatment of AR has addressed many of these anatomical challenges. The JenaValve Trilogy and J-Valve systems incorporate leaflet-grasping mechanisms that enable secure anchoring independent of calcification, resulting in transformation of procedural and clinical outcomes. Recent prospective registry data, including the landmark ALIGN-AR trial, demonstrate high technical and procedural success rates, low residual regurgitation, acceptable safety profiles, and meaningful improvements in functional status and ventricular remodelling. These data have informed contemporary guideline updates, with the 2025 European Society of Cardiology (ESC)\/European Association of Cardiothoracic Surgery (EACTS) Guidelines for the management of valvular heart disease issuing the first conditional recommendation for TAVI in selected patients with severe AR and the National Institute for Health and Care Excellence (NICE) recommending TAVI for native AR in patients for whom surgical AVR is not available or is high risk. This review summarises the clinical implications of AR, examines current guideline recommendations for management, and critically appraises the evidence supporting transcatheter treatment strategies.<\/jats:p>","DOI":"10.3390\/jcm15093206","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:11:14Z","timestamp":1776931874000},"page":"3206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcatheter Aortic Valve Implantation for Pure Aortic Regurgitation"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0896-7956","authenticated-orcid":false,"given":"Samuel","family":"Norman","sequence":"first","affiliation":[{"name":"Department of Cardiology, Leeds General Infirmary, Leeds LS1 3EX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noman","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leeds General Infirmary, Leeds LS1 3EX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blackman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leeds General Infirmary, Leeds LS1 3EX, UK"},{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kalogeropoulos, A.S., Redwood, S.R., Allen, C.J., Hurrell, H., Chehab, O., Rajani, R., Prendergast, B., and Patterson, T. (2022). A 20-year journey in transcatheter aortic valve implantation: Evolution to current eminence. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.971762"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients","volume":"374","author":"Leon","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients","volume":"380","author":"Mack","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","article-title":"Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial","volume":"45","author":"Thyregod","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2025.03.004","article-title":"5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis","volume":"85","author":"Forrest","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","unstructured":"National Cardiac Audit Programme (2025). Transcatheter Aortic Valve Implantation Annual Report, NICOR."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","article-title":"Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey","volume":"140","author":"Iung","year":"2019","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cpcardiol.2017.10.004","article-title":"Aortic Valve Regurgitation: A Comprehensive Review","volume":"43","author":"Akinseye","year":"2018","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jcmg.2023.02.009","article-title":"Burden of Undiagnosed Valvular Heart Disease in the Elderly in the Community: Heart of New Ulm Valve Study","volume":"16","author":"Stanberry","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: A population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","article-title":"Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: The OxVALVE Population Cohort Study","volume":"37","author":"Coffey","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_13","unstructured":"Cohen, D. (2025, January 25\u201328). Findings from the PREVUE-VALVE study presented at TCT 2025. Proceedings of the TCT 2025, San Francisco, CA, USA."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27253","DOI":"10.1038\/srep27253","article-title":"Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China","volume":"2","author":"Shu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)","volume":"83","author":"Singh","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"ref_16","first-page":"145","article-title":"Clinical journey for patients with aortic regurgitation: A retrospective observational study from a multicenter database","volume":"104","author":"Amoroso","year":"2024","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101228","DOI":"10.1016\/j.jacadv.2024.101228","article-title":"Mortality Burden for Patients with Untreated Aortic Regurgitation","volume":"3","author":"Genereux","year":"2024","journal-title":"JACC Adv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/01.CIR.99.14.1851","article-title":"Mortality and morbidity of aortic regurgitation in clinical practice: A long-term follow-up study","volume":"99","author":"Dujardin","year":"1999","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease","volume":"24","author":"Iung","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41598-025-87179-1","article-title":"The healthcare burden of isolated aortic valve insufficiency","volume":"15","author":"Sultan","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.athoracsur.2014.06.050","article-title":"Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients","volume":"99","author":"Thourani","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/24748706.2021.1988779","article-title":"Treatment Patterns, Disparities, and Management Strategies Impact Clinical Outcomes in Patients with Symptomatic Severe Aortic Regurgitation","volume":"5","author":"Thourani","year":"2021","journal-title":"Struct. Heart"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jcin.2017.03.003","article-title":"Toward Precision in Balloon-Expandable TAVR: Oversizing Tight Versus Just Right","volume":"24","author":"Alkhouli","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_24","first-page":"508","article-title":"Multicenter evaluation of transcatheter aortic valve replacement using either SAPIEN XT or CoreValve: Degree of device oversizing by computed-tomography and clinical outcomes","volume":"86","author":"Dvir","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.athoracsur.2011.11.019","article-title":"TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device","volume":"93","author":"Pasic","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"ref_26","first-page":"E939","article-title":"Compassionate use of the self-expandable medtronic CoreValve prosthesis for the treatment of pure aortic regurgitation in a patient at prohibitive risk for surgical valve replacement","volume":"82","author":"Hildebrandt","year":"2013","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jacc.2013.01.018","article-title":"Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation","volume":"61","author":"Roy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4244\/EIJV10I6A127","article-title":"CoreValve implantation for severe aortic regurgitation: A multicentre registry","volume":"10","author":"Testa","year":"2014","journal-title":"EuroIntervention"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","article-title":"Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation","volume":"70","author":"Yoon","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jcin.2023.07.026","article-title":"Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation: The PANTHEON International Project","volume":"28","author":"Poletti","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2017.03.004","article-title":"Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results from an International Registry Study","volume":"10","author":"Sawaya","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jcin.2016.08.049","article-title":"Transcatheter Aortic Valve Replacement for the Treatment of Pure Native Aortic Valve Regurgitation: A Systematic Review","volume":"9","author":"Franzone","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4244\/EIJ-D-25-00224","article-title":"Transcatheter aortic valve implantation in pure aortic regurgitation: One-year outcomes of the AURORA trial","volume":"21","author":"Yu","year":"2025","journal-title":"EuroIntervention"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jcin.2024.05.019","article-title":"Performance of Purpose-Built vs. Off-Label Transcatheter Devices for Aortic Regurgitation: The PURPOSE Study","volume":"17","author":"Poletti","year":"2024","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","article-title":"Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): A prospective, multicentre, single-arm study","volume":"403","author":"Vahl","year":"2024","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gao, L., Mao, R., Zeng, J., and Wen, L. (2025). Single arm meta-analysis of the J-Valve system for aortic regurgitation in Chinese populations. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1436789"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/S0140-6736(25)02215-9","article-title":"Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): A pivotal, multicentre, single-arm, investigational device exemption study","volume":"406","author":"Makkar","year":"2025","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jcin.2014.05.014","article-title":"Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation","volume":"7","author":"Seiffert","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102320","DOI":"10.1016\/j.jaccas.2024.102320","article-title":"Transcaval Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using a Dedicated Self-Expanding Device","volume":"29","author":"Curio","year":"2024","journal-title":"JACC Case Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jcin.2023.07.038","article-title":"Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System","volume":"28","author":"Adam","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.4244\/EIJ-D-24-01117","article-title":"Predictors of pacemaker implantation in aortic regurgitation patients treated with a dedicated transcatheter heart valve","volume":"16","author":"Wienemann","year":"2025","journal-title":"EuroIntervention"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/heart.89.8.901","article-title":"Risk factors for pacemaker implantation following aortic valve replacement: A single centre experience","volume":"89","author":"Limongelli","year":"2003","journal-title":"Heart"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.athoracsur.2007.08.024","article-title":"Permanent pacemaker implantation after isolated aortic valve replacement: Incidence, indications, and predictors","volume":"85","author":"Dawkins","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jtcvs.2017.12.150","article-title":"Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve","volume":"156","author":"Liu","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jcin.2015.08.021","article-title":"A New Transcatheter Aortic Valve Replacement System for Predominant Aortic Regurgitation Implantation of the J-Valve and Early Outcome","volume":"8","author":"Wei","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jcin.2023.05.018","article-title":"Transcatheter Treatment of Native Aortic Valve Regurgitation: The North American Experience with a Novel Device","volume":"16","author":"Garcia","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcin.2024.08.042","article-title":"Meta-Analysis of Dedicated vs. Off-Label Transcatheter Devices for Native Aortic Regurgitation","volume":"18","author":"Samimi","year":"2025","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_48","first-page":"e72","article-title":"2020 ACC\/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur. Heart J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:11:53Z","timestamp":1778127113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15093206"],"URL":"https:\/\/doi.org\/10.3390\/jcm15093206","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}